JACKSONVILLE, Fla., March 15, 2021 /PRNewswire/ -- Johnson & Johnson Vision *, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies **, today introduced a new eye ...

Tenpoint Therapeutics, Ltd., a global, commercial-stage ophthalmic pharmaceutical company focused on developing ...

Yuvezzi is available at retail pharmacies or directly to patients through PHIL, an all-in-one digital hub and ...

- Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye's ability to focus on near objects and affects nearly half of the U.S. adult population, ...

Please provide your email address to receive an email when new articles are posted on . Presbyopia is a very common age-related process that negatively impacts visual performance and quality of life.

The first FDA-approved eye drops to treat age-related blurry near vision (presbyopia) has gone on sale in the US, offering a potential alternative to reading glasses for the estimated 128 million ...

Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...

Presbyopia is defined as age-related loss of near vision that affects nearly everyone over age 45. The FDA has approved Vizz, an aceclidine ophthalmic solution 1.44%, making it the first and only ...

SAN DIEGO -- A low-dose formulation of pilocarpine significantly improved visual acuity in presbyopia without adversely affecting distance vision, results of two randomized trials showed. As compared ...

"Presbyopia Pipeline"Major companies actively shaping the presbyopia treatment landscape include Glaukos Corporation, Orasis Pharmaceuticals, Novartis, Cellix Bio, Visus Therapeutics, AbbVie, Vyluma, ...